drugset / Trial / NCT03274596
Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The retinopathy of prematurity (ROP) is a public health problem, the main causes of ROP are prematurity, use of oxygen, malnutrition and oxidative stress. Vitamin E was used beforehand however its use was stopped because of its association with sepsis and enterocolitis caused by the excipient of vitamin E. The purpose of this study is to use vitamin E to prevent ROP, without the previously used excipients.
Timeline
- Start
- 2013-03-01
- Primary completion
- 2015-10-01
- Completion
- 2015-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vitamin E | Other / unclassified | 12.5 iu | Oral |